Sequential Chemotherapy and Blinatumomab to Improve Minimal Residual Disease in Adult Ph- B-Lineage Acute Lymphoblastic Leukemia. Final Results of the Phase II Gimema LAL2317 TrialSabina Chiaretti, Renato Bassan, Anna Candoni et al.|Blood|2023Cited by 28